Clinical Trial Update: Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

View source ↗

Summary

This clinical trial update describes a noninvasive PET imaging study using 89Zr-labeled AK112 (Ivonescimab) to evaluate antibody distribution and expression in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Ivonescimab (AK112) (ivonescimab)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Esophagus Cancer | Status: NOT_YET_RECRUITING